Vitamin D
Established medicineAlso known as Calciferol, Calciotropic hormone, D Vitamin, Vit.D+4 more
Calciferol, Calciotropic hormone, D Vitamin, Vit.D, Vitamin D NOS, Vitamin D, unspecified form, Vitamin-D, Vitamin D and/or vitamin D derivative.
Recent clinical, regulatory, research and industry developments relating to this drug.
Scientists discover strange link between low vitamin D and pain
Vitamin D Deficiency Needs a Tailored Approach
Study challenges a common belief about vitamin D and sunlight
Study challenges a common belief about vitamin D and sunlight
Molecular Insight into the Role of Vitamin D in Immune-Mediated Inflammatory Diseases.
Evidence confidence
How strongly the incorporated evidence supports specific clinical claims about this treatment. A confidence figure is a current summary of evidence strength, not a permanent verdict.
High point estimate, but substantial uncertainty remains.
— 1 supporting evidence family · 1 well-powered no-effect result
Confidence is moderated by well-powered no-effect evidence and limited publication incorporation.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Pharmacology & targets
Known molecular targets and mechanisms supported by curated pharmacology databases.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- Nutrients10
- International journal of molecular sciences7
- Frontiers in endocrinology2
- The Journal of clinical investigation2
- Acta dermato-venereologica1
- Andrology1
- Bechter O3
- Bennett GG3
- Boecxstaens V3
- Bogaerts K3
- Chan AT3
- Chandler PD3
- De Smedt J3
- Drake BF3
- Brigham and Women's Hospital3
- Clinical and Experimental Endocrinology2
- College of Human Ecology2
- Conway Institute of Biomolecular and Biomedical Research2
- Laboratory for Translational Genetics2
- Laboratory of Dermatology2
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Acts on the same molecular target as Vitamin D, with 9 overlapping disease areas.
Studied across 17 of the same disease areas as Vitamin D in the shared literature.
Studied across 17 of the same disease areas as Vitamin D in the shared literature.
Studied across 12 of the same disease areas as Vitamin D in the shared literature.
Studied across 14 of the same disease areas as Vitamin D in the shared literature.
Studied across 11 of the same disease areas as Vitamin D in the shared literature.
Studied across 7 of the same disease areas as Vitamin D in the shared literature.
Studied across 7 of the same disease areas as Vitamin D in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials